Thank you to @i24News for highlighting our latest #COVID__19 work and my journey as a Chernobyl survivor. #COVID19 .

A pioneer who helped to make cell therapy what it is today.

Microsoft claims AI diagnostic tool can outperform doctors.Research is first initiative from Big Tech group’s AI health unit formed by ex-DeepMind co-founder Mustafa Suleyman.

In a study led by Dr. MLK Chua & team, a deep learning model shows promise in transforming how we assess tumor-infiltrating lymphocytes (TILs) in nasopharyngeal carcinoma (NPC). Using H&E-stained slides, this AI-driven approach (TILDL) accurately quantifies TILs, predicting.

🚀 Advancing CAR T Cell Therapy for Solid Tumors. Current CAR T therapies face challenges in solid tumors due to immunosuppression and antigen diversity. To tackle this, researchers developed 'armoured' CAR T cells that secrete proinflammatory cytokines — but safety concerns have.

RT @GIMedOnc: 🚨I'm hiring at Northwell!🚨. If you—or someone you know—has a passion for using data to drive progress in cancer care, this is….

RT @royaryam: @HemOncFellows @drtulsijose @Noha_Soror @YLeyfman @AviHarisingani @Sai_Wannaphut @rafikelbebmd.

Tumors block dendritic cell migration—can we reverse it?. A new study reveals that as tumors progress, dendritic cells (DCs) lose their ability to migrate to draining lymph nodes, impairing T cell priming and antitumor immunity. Key findings:. ✅ Tumor environments disrupt cGMP.

🌿 The Portfolio Diet Saves Lives — Across Diverse Communities 🫛🥑. New research from a large, racially diverse U.S. cohort shows that greater adherence to the Portfolio Diet — rich in nuts, plant proteins, fiber, phytosterols, and healthy plant fats — is linked to significantly.

RT @Lymphoma_Doc: We have life saving cancer drugs and life threatening shortages. ⁦@jrgralow⁩, @ASCO⁩ staff, and I discuss why, and potent….

New insights into plasma cell dyscrasias from single-cell analysis. In a recent study of 46 patients and 21 healthy donors, single-cell RNA & BCR profiling revealed:. ✅ Residual polyclonal plasma cells (pPCs) decline across disease stages—from MGUS to MM. ✅ Even genotypically.

Is BMI still relevant for predicting health risks?. In a nationally representative study of adults aged 20-49, body fat percentage (BF%) and waist circumference (WC) were stronger predictors of 15-year mortality than BMI. Key findings:. ✅ BF% significantly linked to all-cause &.

A breakthrough for blood cancer detection?. In a Nature Medicine study—published just days after their labs were damaged in an Iranian missile attack—Shlush, Tanay, Furer, Milman & Rappoport reveal a potential game-changer:. A simple blood test analyzing rare circulating stem.

RT @LMikkMD: Extending access for life-saving CAR-T therapies!

Can a digital integrative medicine program reduce cancer-related fatigue?. A randomized trial of 200 patients with solid tumors led by Dr. Jun Mao of Memorial Sloan Kettering Cancer Center tested IM@Home, a 12-week digital program combining exercise and mindfulness, versus.

RT @olsonplanner: There's some potentially big student loan news that can't be acted upon yet (w/ the exception of Parent PLUS loan borrowe….

🚨 Ejaculation Frequency Linked to Lower Prostate Cancer Risk 🚨. New 18-year follow-up data from the Health Professionals Study suggests that higher ejaculation frequency may reduce prostate cancer (PCa) risk — one of the few modifiable factors identified to date. Key Findings:.

🧬 New Discovery: PDI’s Role in DNA Repair & Disease Prevention 🧬. DNA damage drives aging, neurodegeneration, and cancer — but enhancing DNA repair in neurons has remained elusive… until now. 🔬 New research reveals Protein Disulphide Isomerase (PDI) plays a crucial role in.

💉 New Obesity Breakthrough: Monthly MariTide Shows Impressive Results 💉. Phase 2 data reveal that maridebart cafraglutide (MariTide) — a long-acting, once-monthly GLP-1 receptor agonist & GIP receptor antagonist — delivers substantial weight loss in people with obesity, with or.

🚨 New Data: CAR-T Outcomes in Extranodal DLBCL 🚨. Extranodal (EN) DLBCL has long been linked to worse survival, but how do these patients fare after CAR-T therapy? A new multi-center study sheds light:. 🔹 218 patients with EN DLBCL treated with CAR-T in the relapsed/refractory.

🚨 Game-Changer for Type 1 Diabetes? 🩸🔬. Early-phase results from a new study show that zimislecel, an allogeneic stem cell–derived islet-cell therapy, may restore insulin independence in people with Type 1 diabetes. 🧪 In this phase 1–2 trial:. ✅ 100% showed islet.